AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |
| Monashee Investment Management LLC | 275,000 | $2,519,000 | 0.70% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 130,806 | $1,198,183 | 0.64% |
| SILVERBACK ASSET MANAGEMENT LLC | 348,600 | $3,193,176 | 0.43% |
| SCHULHOFF & CO INC | 96,000 | $879,360 | 0.41% |
| Edge Wealth Management LLC | 170,000 | $1,551,250 | 0.36% |
| BRANDES INVESTMENT PARTNERS, LP | 1,444,635 | $13,232,856 | 0.28% |
| Polar Capital Holdings Plc | 4,572,490 | $41,884,008 | 0.27% |
| Portolan Capital Management | 288,325 | $2,641,057 | 0.25% |
| Woodline Partners LP | 1,879,343 | $17,214,782 | 0.23% |
| Modera Wealth Management, LLC | 594,000 | $5,441,040 | 0.21% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q1 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.